Consistently, flow cytometry analysis revealed that HIF-1α inhibitor YC-1, but not the HIF-2α inhibitor TC-S 7009, significantly reduced DMF-induced upregulation of PD-L1 levels on tumor cell surfaces (Fig. 3K). Here, EPAS1 is linked to neoplasm.